BIOMAT Database Logo BIOMAT Database Logo

Non-myeloablative allogeneic stem cell transplantation in children. 2000

R Miniero, and G Zecchina, and A Nagler
Dept. of Biological and Clinical Science, University of Turin, Italy.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell
D019650 Hematopoietic Stem Cell Mobilization The release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of leukapheresis, prior to stem cell transplantation. Hematopoietic growth factors or chemotherapeutic agents often are used to stimulate the mobilization. Stem Cell Mobilization,Mobilization, Stem Cell
D019653 Myeloablative Agonists Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION. Myeloablative Agonist,Agonist, Myeloablative,Agonists, Myeloablative

Related Publications

R Miniero, and G Zecchina, and A Nagler
[Non-myeloablative allogeneic stem cell transplantation].
March 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
R Miniero, and G Zecchina, and A Nagler
Non-myeloablative allogeneic hematopoietic stem cell transplantation.
May 2009, Seminars in oncology nursing,
R Miniero, and G Zecchina, and A Nagler
Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation.
September 2003, The Israel Medical Association journal : IMAJ,
R Miniero, and G Zecchina, and A Nagler
Allogeneic stem cell transplantation and non-myeloablative conditioning regimens.
January 2000, Tumori,
R Miniero, and G Zecchina, and A Nagler
[ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
August 2007, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
R Miniero, and G Zecchina, and A Nagler
[Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation-New Opinion about Hematopoietic Stem Cell Transplantation]
March 2001, Zhongguo shi yan xue ye xue za zhi,
R Miniero, and G Zecchina, and A Nagler
Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation.
May 2002, The Netherlands journal of medicine,
R Miniero, and G Zecchina, and A Nagler
Non-myeloablative allogeneic peripheral stem cell transplantation for multiple myeloma.
April 2004, Hong Kong medical journal = Xianggang yi xue za zhi,
R Miniero, and G Zecchina, and A Nagler
Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma.
January 2003, Urologic oncology,
R Miniero, and G Zecchina, and A Nagler
Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma.
January 2007, Clinical transplantation,
Copied contents to your clipboard!